Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksandra B Lasica

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Neurology and Neuroscience Reports|September 20, 2024
The Role of Mutant IDH Inhibitors in the Treatment of GliomaVihang Nakhate, Aleksandra B Lasica, Patrick Y Wen
Current Opinion in Neurology|August 7, 2025
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspectiveVihang Nakhate, Gilbert Youssef, Aleksandra B Lasica, et al.
Journal of Neurosurgery. Case Lessons|January 20, 2025
Communicating hydrocephalus following stereotactic radiosurgery for periventricular meningiomas: illustrative casesAleksandra B Lasica, Cornel Tancu, Zeid A Abussuud, et al.
World Neurosurgery|April 18, 2021
Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas-A Single-Institution, Nine-Year DataAleksandra B Lasica, Zane Jaunmuktane, Naomi Fersht, et al.
Ageing Research Reviews|January 2, 2025
Association between adult-onset hearing loss and dementia biomarkers: A systematic reviewAleksandra B Lasica, Jack Sheppard, Ruan-Ching Yu, et al.
Neuro-Oncology Advances|February 16, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitorsVihang Nakhate, Catharina Westergaard, Zhou Lan, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neuro-Oncology|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Neurology and Neuroscience Reports|September 20, 2024
The Role of Mutant IDH Inhibitors in the Treatment of GliomaVihang Nakhate, Aleksandra B Lasica, Patrick Y Wen
Current Opinion in Neurology|August 7, 2025
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspectiveVihang Nakhate, Gilbert Youssef, Aleksandra B Lasica, et al.
Journal of Neurosurgery. Case Lessons|January 20, 2025
Communicating hydrocephalus following stereotactic radiosurgery for periventricular meningiomas: illustrative casesAleksandra B Lasica, Cornel Tancu, Zeid A Abussuud, et al.
World Neurosurgery|April 18, 2021
Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas-A Single-Institution, Nine-Year DataAleksandra B Lasica, Zane Jaunmuktane, Naomi Fersht, et al.
Ageing Research Reviews|January 2, 2025
Association between adult-onset hearing loss and dementia biomarkers: A systematic reviewAleksandra B Lasica, Jack Sheppard, Ruan-Ching Yu, et al.
Neuro-Oncology Advances|February 16, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitorsVihang Nakhate, Catharina Westergaard, Zhou Lan, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neuro-Oncology|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Pageof 1